Latham & Watkins LLP is pleased to announce that 23 counsel have been elected to the partnership, effective March 1. The group brings tremendous experience, knowledge,...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Mineralys Therapeutics, and Shearman & Sterling advised the underwriters. Mineralys Therapeutics, Inc. (Nasdaq: MLYS) announced the pricing of its upsized initial public...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented Astorg and OPEN Health in the transaction. OPEN Health, a portfolio company of European private equity firm Astorg, announced the acquisition of...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented ArchiMed and Natus in the transaction. Natus Medical Incorporated (Natus), a leading provider of medical device solutions, has announced the closing...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented Alphatec in the transactions. Alphatec Holdings, Inc. (Nasdaq: ATEC), a medical technology company focusing on surgical treatment for spinal disorders has...
You must be a Standard 1 Year member to access this content.
Cooley advised Geron, while Latham & Watkins represented the underwriters in the offering. Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, has announced the pricing...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Infrared Cameras, while ArentFox Schiff advised SportsMap on the deal. Infrared Cameras Holdings, Inc., a leading provider of intelligent thermal imaging platforms,...
You must be a Standard 1 Year member to access this content.
Covington & Burling LLP advised Indivior, while Latham & Watkins LLP represented Opiant in the transaction. Opiant Pharmaceuticals Inc. (NASDAQ: OPNT) has entered into a definitive...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis and ArentFox Schiff advised Altaris on the deal. Latham & Watkins represented the lenders on the financing aspects. Altaris, LLC, a healthcare investment...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Centerview Partners on the deal, Latham & Watkins represented Imago BioSciences, Gibson Dunn & Crutcher advised Merck. Merck (NYSE: MRK) and Imago BioSciences, Inc....
You must be a Standard 1 Year member to access this content.
Cooley LLP advised Outset, while Latham & Watkins LLP represented SLR Capital Partners in the transaction. Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented MedAlliance in the transaction. Swiss-based medical technology company MedAlliance announced it has entered into an agreement with Cordis for an acquisition which includes...
You must be a Standard 1 Year member to access this content.
